Bioavailability of a formulation containing a diclofenac-ranitidine combination.
Carrasco-Portugal
Miriam Del C
Mdel C
Instituto Nacional de Pediatría, Secretaría de Salud, Universidad Autónoma de San Luis Potosí.
Aguilar-Cota
María E
ME
Pérez-Urizar
José
J
Cabrera
Octavio
O
Herrera
Jorge E
JE
Flores-Murrieta
Francisco J
FJ
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D018592:Cross-Over Studies; D004008:Diclofenac / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D004338:Drug Combinations; D006207:Half-Life; D006801:Humans; D008297:Male; D011899:Ranitidine / Q000008:administration & dosage / Q000493:pharmacokinetics*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D004008:Diclofenac; D011899:Ranitidine